Title for MeetingAbstracts
Alphabetical listing of titles
Risk of AIDS among sex workers in Hungary.
Risk of AIDS and HIV infection in American Indians and Alaska Natives.
Risk of AIDS in patients with herpes zoster, PGL or 'other' features of ARC.
Risk of AIDS in seroconverter drug injectors: a comparison with other risk groups.
Risk of AIDS progression appears early in HIV infection.
Risk of Amprenavir (APV) Rash in HIV Patients with Prior Exposure to Sulfonamides (SULF).
Risk of bacteremia in HIV-infected person with neutropenia.
Risk of bacterial infections in a cohort of HIV-positive patients receiving anti P. carinii/T. gondii prophylaxis.
Risk of Birth Defects Associated with Nelfinavir Exposure during Pregnancy.
Risk of cancer in people with AIDS.
Risk of Catheter-Related Bloodstream Infection (BSI) with Peripherally Inserted Central Venous Catheters (PICCs).
Risk of cerebral toxoplasmosis (C.T.) according to toxoplasmosis seroprevalence in African and European HIV seropositive patients and recommendations for C.T. primary prevention.
Risk of CMV disease in the ERA of protease inhibitors.
Risk of cytomegalovirus (CMV) disease (CD) in persons with HIV (P) having less than 200 CD4.
Risk of cytomegalovirus (CMV) disease in patients with AIDS-related Kaposi's sarcoma (KS) on chemotherapy.
Risk of cytomegalovirus viremia and disease in HIV-infected patients with protease inhibitor treatment failure.
Risk of Death Following Triple Class Virological Failure: the PLATO Collaboration.
Risk of developing a chronic hepatitis among patients co-infected by hepatitis C virus (HCV) and HIV: Bordeaux (France), 1985-1990.
Risk of developing AIDS after HIV seroconversion in injecting drug users: analysis of early markers of disease evolution.
Risk of developing fat tissue alterations in antiretroviral therapy naive women.
Risk of Developing Metabolic Alterations in PI-naive HIV-1 Infected Patients Treated with NRTI.
Risk of Developing Selected de novo Resistance Mutations during Structured Therapy Interruption in Chronic HIV-1 Infection.
Risk of development of HTLV-I-associated myelopathy (HAM/TSP) among persons infected with HTLV-I.
Risk of Development of In Vitro Cross Resistance to Telithromycin and Clarithromycin in Helicobacter pylori Exposed to Telithromycin.
Risk of Development of In Vitro Resistance to Clarithomycin in Helicobacter pylori during Exposure to Antibiotic Combinations.
Risk of disseminated Mycobacterium avium complex infection (DMAC) in person with HIV (P) having less than 200 CD4.
Risk of distribution HIV among women giving sex of services for fee in Dushanbe.
Risk of dyslipidemia in a cohort of 382 HIV-infected subjects receiving lopinavir/ritonavir.
Risk of Emergency Department Visits for Asthma: Frequent Symptoms or Delay in Care.
Risk of Emergency Department Visits for Asthma: Frequent Symptoms or Delay in Care.